Get started
GILEAD SCIENCES INC COM STK USD0.001GILEAD SCIENCES INC COM STK USD0.001GILEAD SCIENCES INC COM STK USD0.001

GILEAD SCIENCES INC COM STK USD0.001

No trades
See on Supercharts
Overview
Financials News Ideas Technicals Forecast

0QYQ chart

Upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats

Market capitalization
‪83.48 B‬USD
Dividend yield (indicated)
4.60%
Price to earnings Ratio (TTM)
187.84
Basic EPS (TTM)
0.38USD
Net income (FY)
‪5.66 B‬USD
Revenue (FY)
‪27.06 B‬USD
Shares float
‪1.24 B‬
Beta (1Y)
0.45

About Gilead Sciences, Inc.

Sector
Health Technology
Industry
Biotechnology
CEO
Daniel P. O'Day
Website
gilead.com
Headquarters
Foster City
Employees (FY)
‪18 K‬
Founded
1987
FIGI
BBG00QG0YFN8
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas

See all ideas 

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Sparks

Curated watchlists where 0QYQ is featured.

See all sparks 

Frequently Asked Questions

The current price of 0QYQ is 67.20 USD — it has decreased by 0.27% in the past 24 hours. Watch GILEAD SCIENCES INC COM STK USD0.001 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSIN exchange GILEAD SCIENCES INC COM STK USD0.001 stocks are traded under the ticker 0QYQ.
0QYQ stock has risen by 3.07% compared to the previous week, the month change is a 0.41% fall, over the last year GILEAD SCIENCES INC COM STK USD0.001 has showed a 14.14% decrease.
We've gathered analysts' opinions on GILEAD SCIENCES INC COM STK USD0.001 future price: according to them, 0QYQ price has a max estimate of 117.00 USD and a min estimate of 67.00 USD. Watch 0QYQ chart and read a more detailed GILEAD SCIENCES INC COM STK USD0.001 stock forecast: see what analysts think of GILEAD SCIENCES INC COM STK USD0.001 and suggest that you do with its stocks.
0QYQ reached its all-time high on Dec 13, 2022 with the price of 89.58 USD, and its all-time low was 56.60 USD and was reached on Dec 31, 2020. View more price dynamics on 0QYQ chart.
See other stocks reaching their highest and lowest prices.
0QYQ stock is 1.62% volatile and has beta coefficient of 0.45. Track GILEAD SCIENCES INC COM STK USD0.001 stock price on the chart and check out the list of the most volatile stocks — is GILEAD SCIENCES INC COM STK USD0.001 there?
Today GILEAD SCIENCES INC COM STK USD0.001 has the market capitalization of ‪83.48 B‬, it has decreased by 1.76% over the last week.
Yes, you can track GILEAD SCIENCES INC COM STK USD0.001 financials in yearly and quarterly reports right on TradingView.
GILEAD SCIENCES INC COM STK USD0.001 is going to release the next earnings report on Aug 8, 2024. Keep track of upcoming events with our Earnings Calendar.
0QYQ earnings for the last quarter are −1.32 USD per share, whereas the estimation was −1.49 USD resulting in a 11.60% surprise. The estimated earnings for the next quarter are 1.59 USD per share. See more details about GILEAD SCIENCES INC COM STK USD0.001 earnings.
GILEAD SCIENCES INC COM STK USD0.001 revenue for the last quarter amounts to ‪6.69 B‬ USD despite the estimated figure of ‪6.36 B‬ USD. In the next quarter revenue is expected to reach ‪6.71 B‬ USD.
0QYQ net income for the last quarter is ‪−4.17 B‬ USD, while the quarter before that showed ‪1.43 B‬ USD of net income which accounts for −391.81% change. Track more GILEAD SCIENCES INC COM STK USD0.001 financial stats to get the full picture.
Yes, 0QYQ dividends are paid quarterly. The last dividend per share was 0.77 USD. As of today, Dividend Yield (TTM)% is 4.51%. Tracking GILEAD SCIENCES INC COM STK USD0.001 dividends might help you take more informed decisions.
GILEAD SCIENCES INC COM STK USD0.001 dividend yield was 3.70% in 2023, and payout ratio reached 66.62%. The year before the numbers were 3.40% and 80.25% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of May 17, 2024, the company has ‪18.00 K‬ employees. See our rating of the largest employees — is GILEAD SCIENCES INC COM STK USD0.001 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GILEAD SCIENCES INC COM STK USD0.001 EBITDA is ‪12.08 B‬ USD, and current EBITDA margin is 45.96%. See more stats in GILEAD SCIENCES INC COM STK USD0.001 financial statements.
Like other stocks, 0QYQ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GILEAD SCIENCES INC COM STK USD0.001 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GILEAD SCIENCES INC COM STK USD0.001 technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GILEAD SCIENCES INC COM STK USD0.001 stock shows the sell signal. See more of GILEAD SCIENCES INC COM STK USD0.001 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.